Absci Corp. (ABSI)
8.45
-0.68
(-7.50%)
USD |
NASDAQ |
Nov 13, 16:00
8.47
+0.02
(+0.24%)
After-Hours: 19:59
Absci Gross Profit Margin (Quarterly) : -784.2% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -784.2% |
| June 30, 2026 | -747.8% |
| March 31, 2026 | -1.17K% |
| December 31, 2025 | -335.1% |
| September 30, 2025 | -651.9% |
| June 30, 2025 | -405.9% |
| March 31, 2025 | -160.6% |
| December 31, 2024 | -386.3% |
| September 30, 2024 | -97.24% |
| June 30, 2024 | -166.5% |
| March 31, 2024 | -280.4% |
| December 31, 2023 | -930.8% |
| September 30, 2023 | -372.2% |
| June 30, 2023 | -3.89% |
| Date | Value |
|---|---|
| March 31, 2023 | -176.1% |
| December 31, 2022 | -130.3% |
| September 30, 2022 | -43.69% |
| June 30, 2022 | -213.5% |
| March 31, 2022 | -254.8% |
| December 31, 2021 | -90.01% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Twist Bioscience Corp. | 53.10% |
| Moderna, Inc. | 70.60% |
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Recursion Pharmaceuticals, Inc. | -9.13% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.62% |
| Return on Assets | -53.92% |
| Return on Invested Capital | -59.30% |
| Profit Margin (Quarterly) | -10.95K% |
| Operating Margin (Quarterly) | -11.51K% |
| Return on Net Operating Assets | -201.1% |